Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mundipharma Research Limited

Clinical trials sponsored by Mundipharma Research Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for rare lung infection: weekly drug shows promise in early trial Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 2

New hope for rare lung infection: weekly drug shows promise in early trial

Disease control Ongoing

This study tests a drug called rezafungin for people with a long-term lung infection caused by a fungus (chronic pulmonary aspergillosis) who have few other treatment choices. About 60 adults will receive the drug once a week for 6 months. Researchers will check if the treatment …

Phase 2 • Sponsor: Mundipharma Research Limited • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC